Today: 23 May 2026
Exxon stock nears 52-week high as winter storm lifts oil prices ahead of earnings
28 January 2026
2 mins read

Exxon stock nears 52-week high as winter storm lifts oil prices ahead of earnings

New York, Jan 27, 2026, 19:31 EST — Trading after hours.

  • Exxon Mobil shares ended the day up 1.5%, closing at $136.83, then saw little movement in after-hours trading
  • Oil climbed roughly 3% after supply disruptions tied to the storm; Exxon announced it was shutting units at Baytown
  • All eyes turn to Exxon’s quarterly report on Friday, as investors zero in on refining margins and outage updates

Exxon Mobil Corporation shares closed Tuesday up 1.5% at $136.83 and stayed near that mark in after-hours trading, matching gains seen across major oil players like Chevron, BP, and Shell.

Why it matters now: the stock is once again moving like a stand-in for crude, with fresh market focus on U.S. supply issues and refining hiccups. A winter storm in the U.S. is at the center, forcing energy traders to adjust prices on near-term barrels and related products.

The report arrives just two days ahead of Exxon’s fourth-quarter earnings and conference call. Investors will be focused on any operational impact from the freeze, along with management’s outlook on 2026 spending and returns.

Oil prices jumped nearly 3% on Tuesday as a storm knocked U.S. production offline and briefly halted Gulf Coast crude exports, Reuters reported. “Short-term risks [are] tilted to the upside on fears of supply disruptions,” said Fawad Razaqzada, a market analyst at City Index. Tamas Varga from PVM warned the cold snap could cause “significant drawdowns in oil stocks” if it continues. Reuters

Exxon announced it was shutting down units at its Baytown, Texas petrochemical complex due to freezing conditions. The site houses a refinery processing 564,440 barrels per day. Flaring, a safety measure involving burning hydrocarbons when units can’t operate normally, was also spotted in other parts of the Gulf Coast during the cold snap.

Separately, China’s BYD announced it will expand its hybrid-technology collaboration with Exxon through a long-term memorandum of understanding. This non-binding deal outlines plans for joint efforts like customised product research and new material applications. The two firms unveiled a jointly developed engine oil for BYD plug-in hybrids just last year.

Exxon climbed close to its previous session’s 52-week peak, despite mixed U.S. stock performance—S&P 500 edged up while the Dow slipped. Trading volume for Exxon ran below its recent average, MarketWatch reported.

Exxon shareholders know the drill: rising crude prices boost upstream profits, and winter outages can jolt product markets and refining margins fast. Integrated majors often move on any sign of ongoing disruption, even if the hit to an individual facility is tough to quantify.

That storm story works both ways. If production and exports bounce back quicker than forecast — or if international supply steadies sooner — crude prices could fall, making the stock’s recent rally look overdone. A prolonged outage at Baytown would add to the risk, potentially slashing volumes and boosting costs, clouding the outlook for earnings.

Friday’s quarterly report is the next major catalyst, with results set to drop premarket. Executives will follow up with a management call and Q&A later that morning.

Stock Market Today

  • NVIDIA Shares Fall 1.9% Following Analyst Downgrade Amid Insider Sales
    May 22, 2026, 6:44 PM EDT. NVIDIA (NASDAQ:NVDA) shares dropped 1.9% to $215.33 on Friday after New Street Research cut its price target slightly to $340 from $343. Trading volume was around 3% below average. Despite this, other firms like Tigress Financial and Daiwa Securities maintain optimistic views with strong buy ratings and price targets up to $400. CFO Colette Kress and EVP Ajay K. Puri sold significant stock portions, reducing their holdings by 4.62% and 9.04% respectively, amid record Q1 AI-driven demand and a new $80 billion share buyback. The stock holds a strong consensus Buy rating with a $303.27 target, reflecting continued investor interest in NVIDIA's data center growth and margin strength.

Latest articles

Peloton Shares Surge 10% as Index Funds Set to Buy

Peloton Shares Surge 10% as Index Funds Set to Buy

23 May 2026
Peloton shares closed up 10.23% at $5.71 after S&P Dow Jones Indices announced the company will join the S&P SmallCap 600 before May 27. Trading volume hit 34.9 million shares, more than double the 50-day average. The move follows Peloton’s recent report of $630.9 million in quarterly revenue and a 70% drop in net debt. U.S. markets will close May 25 for Memorial Day.
POET Shares Drop Again With $400M AI Optics Push Raising Dilution Concerns

POET Shares Drop Again With $400M AI Optics Push Raising Dilution Concerns

23 May 2026
POET Technologies shares fell 1.55% to $14.59 Friday on Nasdaq, despite closing a $400 million private placement with one institutional investor. The company issued 19.05 million shares and warrants, aiming to expand manufacturing capacity tenfold. Trading volume reached 33.4 million shares, down from last week’s spike. First-quarter revenue was $503,389 with a net loss of $12.3 million.
Artelo Biosciences Stock Just Whipsawed — Here’s What Traders Are Watching Now

Artelo Biosciences Stock Just Whipsawed — Here’s What Traders Are Watching Now

23 May 2026
Artelo Biosciences shares fell 10.5% to $1.19 Friday, then jumped to $2.01 in after-hours trading. The company activated a $75 million shelf registration May 19 and ended its at-the-market stock-sale agreement after raising $451,527. Artelo reported a Q1 net loss of $3 million and held $10.3 million in cash and investments as of March 31.
Texas Instruments stock jumps after upbeat forecast, new data-center disclosure grabs focus
Previous Story

Texas Instruments stock jumps after upbeat forecast, new data-center disclosure grabs focus

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next
Next Story

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Go toTop